Skip to Main Content

FDA-cleared software for advanced brain tumor analyses

Powered by AI and advanced diffusion MRI, OnQ Neuro assists radiologists, oncologists, and the Tumor Board by providing objective quantification and analysis of tumor changes over time.

Precision AI

OnQ Neuro enables more precise quantification and visualization of brain tumors with 3D volumetrics.

Play video

Benefits

High- and low-grade glioma

Slice by slice tumor segmentation in DICOM format

Longitudinal disease assessment

Automated quantification and tracking of pre- and post-treatment brain tumor volumes across time

Clinical trial support

Objective tumor quantification for improved confidence and efficiency

Unique microstructure insights

Patented Restriction Spectrum Imaging (RSI) advanced diffusion technology

OnQ™ Neuro report

Comprehensive segmentation and volumetrics reporting, automatically routed to PACS.

The OnQ™ Neuro report

Provides tumor boards with a time series of brain tumor volume analysis across scans. 3D volumetrics are displayed for tumor ROIs that enable more efficient and objective reviews.